Morphogenesis Inc. | Finanzwire

Basculer en Français

9984	Companies
202390	Keywords
133028	Articles
107483	Press releases

Home
Companies
Morphogenesis Inc.

BRIEF

published on 04/25/2024 at 15:05, 1 year 10 months ago

TuHURA Biosciences to Showcase Clinical Trial Results at ASCO 2024

Clinical Trials Mergers And Acquisitions TuHURA Biosciences Cancer Immunotherapy ASCO 2024
PRESS RELEASE

published on 04/25/2024 at 15:00, 1 year 10 months ago

TuHURA Biosciences to Present Its IFx-2.0 Personalized Cancer Vaccine Clinical Trial Results at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
TuHURA Biosciences, Inc. announces IFx-2.0 Phase 1b trial results accepted for poster presentation at 2024 ASCO Annual Meeting. Company to form new entity with Kintara Therapeutics, Inc. and focus on cancer vaccines and bi-functional ADCs

Phase 1b Trial TuHURA Biosciences Inc. IFx-2.0 Poster Presentation Kintara Therapeutics Inc.
PRESS RELEASE

published on 12/14/2023 at 16:00, 2 years 2 months ago

Morphogenesis, Inc. Announces Corporate Rebranding to TuHURA Biosciences, Inc. and Provides a Business Overview
PRESS RELEASE

published on 11/08/2023 at 15:00, 2 years 3 months ago

Morphogenesis, Inc. Biomarker Analysis Data from IFx-Hu2.0 in Melanoma Refractory to Anti-PD1-Based Therapies Demonstrates Ability to Overcome Primary Resistance to Checkpoint Inhibitors and Trigger an Innate Immune Response

Accesswire

Published on 03/05/2026 at 17:55, 1 hour 9 minutes ago

ACCESS Newswire to Host Fourth Quarter and Year End Earnings Conference Call on March 19, 2026
Published on 03/05/2026 at 14:00, 5 hours 4 minutes ago

EQ Inc. Secures Strategic Partnership with Global Card Network to Expand Integrated Rewards Across Canada
Published on 03/05/2026 at 14:00, 5 hours 4 minutes ago

GameSquare's Stream Hatchet Publishes 2025 YouTube Gaming Trends Report
Published on 03/05/2026 at 14:00, 5 hours 4 minutes ago

Horizon Aircraft's Unique VTOL Delivers Up to 75% Lower Operating Costs Than Helicopters
Published on 03/05/2026 at 13:40, 5 hours 24 minutes ago

Lobe Sciences Ltd. Announces Presence in Miami During the Jefferies and Leerink Healthcare Conferences

View all ACCESSWIRE

EQS Group

Published on 03/05/2026 at 18:48, 15 minutes ago

POS-Transaction in Own Shares
Published on 03/05/2026 at 18:17, 46 minutes ago

Cairn Homes Plc: Holding(s) in Company
Published on 03/05/2026 at 17:57, 1 hour 7 minutes ago

EQS-Adhoc: Delivery Hero SE may redeem convertible bonds in H1 2026 using proceeds from a USD 1.5bn increase of its term loans subject to certain conditions
Published on 03/05/2026 at 17:48, 1 hour 15 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/05/2026 at 17:45, 1 hour 19 minutes ago

Swiss Prime Site announces the conversion price of its CHF 350 million green convertible bonds due 2032 and the outcome of the incentivized conversion invitation

Les Echos

Published on 03/05/2026 at 18:40, 24 minutes ago

2025 Full-year results FREY: a pan-European platform already creating value
Published on 03/05/2026 at 18:34, 29 minutes ago

Mersen: Number of shares and voting rights as of February 28, 2026
Published on 03/05/2026 at 17:45, 1 hour 19 minutes ago

February 2026
Published on 03/05/2026 at 17:45, 1 hour 19 minutes ago

Cie du Bois Sauvage : Results 2025
Published on 03/05/2026 at 13:20, 5 hours 43 minutes ago

Voting rights

View all LES ECHOS COMFI WIRE